Advertisement
Screener

Inspire Medical Systems, Inc. (INSP) Graph

INSP Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $200.58M; Cost of revenue $29.12M; Research and development $24.70M; Selling, general and administrative $147.28M.
  • 2026-03-31: Revenue $204.58M; Cost of revenue $27.67M; Research and development $25.83M; Selling, general and administrative $152.20M.
  • 2025-12-31: Revenue $269.08M*; Cost of revenue $36.07M*; Research and development $24.94M*; Selling, general and administrative $161.95M*.
  • 2025-09-30: Revenue $224.50M; Cost of revenue $31.77M; Research and development $24.21M; Selling, general and administrative $158.87M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

INSP revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$13.28MUS$187.30MRevenue$200.58MCost of revenue$29.12MGross profit$171.46MOperating income-$514.00KOther income, net-$110.00KResearch & development$24.70MSelling, general& administrative$147.28MPre-tax income$3.12MIncome tax$2.80MNet income$314.00K

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

INSP revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Operating Segment$200.58MRevenue$200.58MCost of revenue$29.12MGross profit$171.46MOperating income-$514.00KOther income, net-$110.00KResearch & development$24.70MSelling, general& administrative$147.28MPre-tax income$3.12MIncome tax$2.80MNet income$314.00K

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$200.58M$29.12M$24.70M$147.28M(m)$2.80M$314.00K
2026-03-31$204.58M$27.67M$25.83M$152.20M(m)$13.69M-$11.29M
2025-12-31$269.08M*$36.07M*$24.94M*$161.95M*(m)-$85.77M*$136.09M*
2025-09-30$224.50M$31.77M$24.21M$158.87M(m)$3.62M$9.93M
2025-06-30$217.09M$34.67M$26.21M$159.52M(m)$1.26M-$3.59M
2025-03-31$201.32M$30.71M$27.80M$144.29M(m)$1.17M$2.99M
2024-09-30$203.19M$32.40M$26.08M$130.39M$156.47M$1.83M$18.50M
2024-06-30$195.88M$29.84M$28.86M$132.08M$160.94M$1.05M$9.79M
2024-03-31$164.01M$24.76M$28.85M$125.62M$154.47M$650.00K-$10.01M
2023-09-30$153.30M$24.38M$29.14M(m)$142.39M$340.00K-$8.54M
2023-06-30$151.09M$24.25M$30.82M(m)$143.44M$214.00K-$11.95M
2023-03-31$127.90M$19.89M$25.52M(m)$127.51M$216.00K-$15.42M
2022-09-30$109.19M$19.79M$20.99M(m)$106.60M$246.00K-$16.85M
2022-06-30$91.39M$14.17M$14.53M(m)$91.22M$142.00K-$14.49M
2022-03-31$69.38M$10.00M$11.87M(m)$75.43M$100.00K-$16.69M
2021-09-30$61.69M$8.62M$9.61M(m)$62.86M$3.00K-$10.35M
2021-06-30$52.96M$7.52M$9.29M(m)$57.98M$26.00K-$13.09M
2021-03-31$40.35M$5.98M$8.15M(m)$50.06M$23.00K-$16.22M
2020-12-31$46.01M(m)(m)(m)(m)(m)-$7.48M
2020-09-30$35.84M$5.21M$7.31M(m)$40.52M$87.00K-$10.38M
2020-06-30$12.18M$1.95M$6.06M(m)$33.04M$0.00-$23.09M
2020-03-31$21.35M$3.30M$5.44M(m)$34.49M$0.00-$16.25M
2019-12-31$26.91M(m)(m)(m)(m)(m)-$9.08M
2019-09-30$20.86M$3.46M$3.62M(m)$26.06M$0.00-$8.25M
2019-06-30$18.03M$3.09M$2.85M(m)$23.11M$0.00-$7.65M
2019-03-31$16.25M$2.85M$2.60M(m)$22.17M$0.00-$8.27M
2018-12-31$16.56M(m)(m)(m)(m)(m)-$4.78M
2018-09-30$13.05M$2.47M$1.77M(m)$15.24M$0.00-$4.69M
2018-06-30$10.94M$2.10M$1.74M(m)$14.47M$0.00-$5.86M
2018-03-31$10.04M$2.29M$1.73M(m)$12.94M$0.00-$6.50M
2017-12-31$9.96M(m)(m)(m)(m)(m)-$4.25M
2017-09-30$7.27M$1.56M$1.18M(m)$9.36M$0.00-$4.02M
2017-06-30$6.04M$1.38M$1.74M(m)$9.05M(m)-$4.76M
2017-03-31$5.30M$1.20M$1.59M(m)$8.22M(m)-$4.48M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$405.16M$56.79M$50.52M$299.48M(m)$16.49M-$10.98M
2025-06-30$418.40M$65.38M$54.01M$303.81M(m)$2.43M-$600.00K
2024-06-30$359.89M$54.60M$57.71M$257.70M$315.41M$1.70M-$212.00K
2023-06-30$278.99M$44.14M$56.34M(m)$270.95M$430.00K-$27.38M
2022-06-30$160.77M$24.18M$26.40M(m)$166.65M$242.00K(m)
2021-06-30$93.31M$13.50M$17.44M(m)$108.05M$49.00K(m)
2020-06-30$33.53M$5.25M$11.50M(m)$67.53M$0.00(m)
2019-06-30$34.28M$5.95M$5.45M(m)$45.29M$0.00-$15.92M
2018-06-30$20.98M$4.40M$3.46M(m)$27.42M$0.00-$12.36M
2017-06-30$11.34M$2.57M$3.34M(m)$17.27M(m)-$9.24M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$642.90M$97.15M$78.22M$462.68M(m)$6.05M$9.33M
2024-09-30$563.09M$87.00M$83.79M$388.10M$471.89M$3.53M$18.29M
2023-09-30$432.29M$68.52M$85.48M(m)$413.34M$770.00K-$35.92M
2022-09-30$269.96M$43.96M$47.40M(m)$273.25M$488.00K(m)
2021-09-30$155.00M$22.12M$27.06M(m)$170.90M$52.00K(m)
2020-09-30$69.37M$10.46M$18.81M(m)$108.06M$87.00K(m)
2019-09-30$55.14M$9.40M$9.07M(m)$71.34M$0.00-$24.16M
2018-09-30$34.03M$6.86M$5.24M(m)$42.65M$0.00-$17.05M
2017-09-30$18.61M$4.14M$4.51M(m)$26.63M$0.00-$13.26M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$911.98M$133.22M$103.17M$624.64M(m)-$79.72M$145.42M
2024-12-31$802.80M$122.99M$114.13M$529.61M(m)$4.94M$53.51M
2023-12-31$624.80M$96.58M$116.54M$451.96M$568.49M$1.25M-$21.15M
2022-12-31$407.86M$66.11M$68.64M$320.69M$389.33M$613.00K-$44.88M
2021-12-31$233.39M$33.28M$37.35M$202.62M$239.97M$72.00K-$42.04M
2020-12-31$115.38M$17.62M$26.09M$127.87M$153.97M$115.00K-$57.20M
2019-12-31$82.05M$13.64M$12.84M$90.47M$103.30M$40.00K-$33.24M
2018-12-31$50.59M$10.06M$7.39M$53.53M$60.91M$0.00-$21.83M
2017-12-31$28.57M$6.02M$6.19M$32.36M$38.55M$0.00-$17.51M
2016-12-31$16.43M$3.90M$7.09M$22.68M$29.77M$0.00-$18.53M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77